Insulin glargine U-300 Max 300 [iU]/mL
insulin glargine · INJECTION, SOLUTION · Sanofi-Aventis U.S. LLC
Insulin glargine U-300 Max is a injection, solution containing insulin glargine at 300 [iU]/mL, taken subcutaneous. Manufactured by Sanofi-Aventis U.S. LLC.
Key Facts
- Brand Name
- Insulin glargine U-300 Max
- Generic Name
- insulin glargine
- NDC Code (Product)
0955-2900- Manufacturer
- Sanofi-Aventis U.S. LLC
- Strength
- 300 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA206538
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 04/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Insulin glargine U-300 Max used for?
Insulin glargine U-300 Max contains insulin glargine. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Insulin glargine U-300 Max a controlled substance?
Insulin glargine U-300 Max is not classified as a controlled substance by the DEA.
What is the generic name for Insulin glargine U-300 Max?
The generic name for Insulin glargine U-300 Max is insulin glargine. There are 11 other brand versions of insulin glargine.
What is the NDC code for Insulin glargine U-300 Max 300 [iU]/mL?
The NDC (National Drug Code) for Insulin glargine U-300 Max 300 [iU]/mL is 0955-2900, listed by Sanofi-Aventis U.S. LLC.
Other Insulin Brands
See all →- Insulin Glargine100 [iU]/mL83257-015
- BASAGLAR Tempo Pen100 [iU]/mL0002-8214
- TOUJEO Max300 U/mL0024-5871
- INSULIN GLARGINE100 [iU]/mL72572-424
- SEMGLEE100 [iU]/mL83257-012
- LANTUS SOLOSTAR100 [iU]/mL50090-4068
- REZVOGLAR KWIKPEN100 [iU]/mL50090-6439
- Insulin Glargine100 [iU]/mL83257-014
- Lantus100 [iU]/mL50090-0876
- TOUJEO300 U/mL0024-5869
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)